Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases
BackgroundOne of the most significant recent advancements in cancer immunotherapy is the development of chimeric antigen receptor (CAR) technology. More recently, this approach has been gradually modified for the research associated with various treatm…